Who
Peter Benedict
Chief Information Officer
Company insider
Files Form 4 as: Chief Information Officer, USANA Health Sciences.
In numbers
- Trades disclosed
- 52
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $232K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 25 Jul 2024
- Last trade
- 25 Jul 2026
- Last filed
- 27 Jul 2026
Companies traded
Activity over time
1 Dec 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 25 Jul 2026filed 27 Jul 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code M | —598 | filing |
| 25 Jul 2026filed 27 Jul 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code F | $3,752176 at $21.32 | filing |
| 25 Jul 2026filed 27 Jul 2026 | USNA USANA Health Sciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —598 at $0.00 | filing |
| 25 Jul 2026filed 27 Jul 2026 | USNA USANA Health Sciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —598 at $0.00 | filing |
| 25 Jul 2026filed 27 Jul 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code M | —598 | filing |
| 25 Jul 2026filed 27 Jul 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code F | $3,752176 at $21.32 | filing |
| 3 Mar 2026filed 3 Mar 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Sold | $88K4,553 at $19.38 | filing |
| 3 Mar 2026filed 3 Mar 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Sold | $88K4,553 at $19.38 | filing |
| 27 Feb 2026filed 3 Mar 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code M | —3,906 | filing |
| 27 Feb 2026filed 3 Mar 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code F | $25K1,174 at $21.52 | filing |
| 27 Feb 2026filed 3 Mar 2026 | USNA USANA Health Sciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —3,906 at $0.00 | filing |
| 27 Feb 2026filed 3 Mar 2026 | USNA USANA Health Sciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —3,906 at $0.00 | filing |
| 27 Feb 2026filed 3 Mar 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code M | —3,906 | filing |
| 27 Feb 2026filed 3 Mar 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code F | $25K1,174 at $21.52 | filing |
| 19 Feb 2026filed 23 Feb 2026 | USNA USANA Health Sciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —21,775 at $0.00 | filing |
| 19 Feb 2026filed 23 Feb 2026 | USNA USANA Health Sciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —21,775 at $0.00 | filing |
| 8 Feb 2026filed 10 Feb 2026 | USNA USANA Health Sciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —1,157 at $0.00 | filing |
| 8 Feb 2026filed 10 Feb 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code M | —1,157 | filing |
| 8 Feb 2026filed 10 Feb 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code F | $8,557401 at $21.34 | filing |
| 8 Feb 2026filed 10 Feb 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code M | —1,157 | filing |
News
No headline names them, or the companies they trade most, lately.